Within its goal of pushing science forward and bringing to developing countries, the Gates Foundation has outlined vaccine delivery as a key part of its strategy.
The foundation has invested in communications to emphasize the importance of vaccines (such as the work of Zim & Zou), but is also tackling a more technical challenge – the price of vaccines.
Vaccines are often expensive for the world’s poorest countries. Along with supply shortages and a lack of trained health workers, this leads to a sad fact – an estimated 1.5 million children die each year from vaccine-preventable diseases.
Now, Bill&Melinda Foundation has awarded Batavia Biosciences a €3.3M ($3.8M) grant. Based in Leiden (Netherlands), Batavia will use it expertise in manufacturing to cut costs in the process through which cells produce specific virus –